Clinical Trial Update: Imaging Based Dosimetry for Individualized Internal Emitter Therapy

View source ↗

Summary

Completed trial evaluating imaging-based dosimetry to individualize internal emitter therapy for Non-Hodgkin's Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Michigan | Conditions: Non-Hodgkin's Lymphoma | Status: COMPLETED